Search

Author/Creator Iacobello, C.

2. Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort. Issue 1 (February 2018)

Authors:
Calvaruso, V.; Petta, S.; Cacciola, I.; Cabibbo, G.; Cartabellotta, F.; Di Rosolini, A.; Davì, A.; Cannavò, M.; Russello, M.; Distefano, M.; Scifo, G.; Di Lorenzo, F.; Prestileo, T.; La Rocca, L.; Montineri, A.; Fiduli, G.; Digiacomo, A.; Cannizzaro, M.; Madonia, S.; Licata, A.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs). Issue 1 (16th February 2017)

Authors:
Calvaruso, V.; Cabibbo, G.; Cacciola, I.; Petta, S.; Madonia, S.; Bellia, A.; Tinè, F.; Distefano, M.; Giannitrapani, L.; Prestileo, T.; Mazzola, G.; Davì, A.; Larocca, L.; Ardiri, A.; Digiacomo, A.; Gussio, M.; Guarneri, L.; Magro, A.; Averna, A.; Iacobello, C.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry. Issue 1 (16th February 2017)

Authors:
Cacciola, I.; Petta, S.; Distefano, M.; Cannavò, M.R.; Davì, A.; Madonia, S.; Calvaruso, V.; Larocca, L.; Di Lorenzo, F.; Digiacomo, A.; Bertino, G.; Licata, A.; Latteri, F.; Benanti, F.; Volpes, R.; Guarneri, L.; Averna, A.; Scalisi, I.; Iacobello, C.; Colletti, P.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. PC.01.10 LIVER AND CARDIOVASCULAR MORTALITY AFTER DAAS: DATA FROM THE RESIST-HCV COHORT. (25th March 2019)

Authors:
Magro, B.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cabibbo, G.; Cartabellotta, F.; Di Rosolini, A.; Davì, A.; Cannavò, M.; Russello, M.; Di Stefano, M.; Scifo, G.; Di Lorenzo, F.; Prestileo, T.; Rocca, L. La; Montineri, A.; Fuduli, G.; Digiacomo, A.; Cannizzaro, M.; Madonia, S.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 2
Page Start:
e75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs). Issue 1 (16th February 2017)

Authors:
Cabibbo, G.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Calvaruso, V.; Petta, S.; Distefano, M.; Larocca, L.; Prestileo, T.; Tinè, F.; Digiacomo, A.; Bertino, G.; Giannitrapani, L.; Benanti, F.; Davì, A.; Volpes, R.; Scalisi, I.; Iacobello, C.; Mazzola, G.; Cartabellotta, F.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort. (October 2019)

Authors:
Cacciola, I.; Petta, S.; Calvaruso, V.; Cartabellotta, F.; Distefano, M.; Scifo, G.; Di Lorenzo, F.; Sanfilippo, A.; Di Rosolini, M.A.; Davì, A.; Benanti, F.; Cacopardo, B.; Licata, A.; Giannitrapani, L.; Cannavò, M.R.; Russello, M.; Madonia, S.; Bavetta, M.G.; Digiacomo, A.; Averna, A.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 3
Page Start:
e262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗